Skip to main content
. 2017 Jun 9;130(4):440–452. doi: 10.1182/blood-2017-03-735639

Figure 1.

Figure 1.

DNA sources for MRD detection in hematologic malignancies. Graphic overview of distinct DNA sources for molecular disease profiling in hematologic neoplasms, which include circulating tumor DNA as part of the circulating cell-free DNA pool and circulating tumor cells in the bloodstream as well as malignant cells in the BM compartment. Their main characteristics and role in hematologic cancers are displayed in the table next to the graphic.